SynthesisNeuroscience and biobehavioral reviews2026
Mechanistic link of obesity to depression and cognitive decline in Alzheimer's disease.
Synthesis in Neuroscience and biobehavioral reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The global rise in obesity and metabolic dysfunction has heightened concern about their links to depression, cognitive impairment, and Alzheimer's disease (AD)-related pathology. High-fat diet (HFD) exposure, excess adiposity, and metabolic dysfunction may each contribute to these outcomes, but they represent biologically distinct conditions that should not be treated as interchangeable. Epidemiological evidence suggests links between these conditions, yet the molecular pathways connecting them remain poorly characterized. This systematic review synthesizes current evidence on how HFD exposure, excess adiposity, and metabolic dysfunction may engage overlapping mechanisms associated with depression-related outcomes, cognitive impairment, and AD-related pathology. We propose an integrated biomechanistic model illustrating how HFD exposure may contribute to depression-related outcomes, cognitive impairment, and AD-related pathology through partially overlapping mechanisms. It is presented as a molecular formulation of the classical stress-diathesis perspective, highlighting how dietary exposures may interact with preexisting vulnerabilities, including genetic, epigenetic, and environmental factors, to compromise the brain's adaptive capacity to various stressors. Finally, we discuss translational implications, identifying potential targets for interventions-dietary, pharmacological, and lifestyle-with relevance to shared mechanisms underlying depression-related and cognitive outcomes, while highlighting critical gaps in understanding-such as sex-specific effects, developmental timing, and human translational evidence-that warrant further research. Human evidence remains largely observational and does not establish that these mechanisms operate equivalently in clinically diagnosed depression or AD. Future longitudinal studies integrating dietary exposure, metabolic and inflammatory biomarkers, neuroimaging, cognitive assessment, and clinical diagnoses are needed to define human vulnerability better and to provide targeted prevention and intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.